Hidradenitis suppurativa often goes undiagnosed for years while patients quietly absorb pain, odor, and isolation. The panel examines why recognizing these signals early changes everything that follows.
HS in Practice: Case-Based Approaches to Advancing Care
Three FDA-approved biologics now intercept the inflammatory cascade at different points, yet Dr. Laura Bush argues a calm exam can understate real disease burden. The panel discusses when history should outweigh appearance.
Trending on Dermatology Times
1
Clascoterone 5% Topical Solution Shows Long-Term Promise for Male Pattern Hair Loss
2
Dersimelagon NDA Accepted by FDA with Priority Review for EPP, XLP
3
North Immunology, Aethlon Merge to Advance NOR-101 for AD
4
Maui Derm NP+PA Fall 2026: Key Clinical Takeaways From 4 Days of Dermatology Education
5